RCKT compared with MIST: revenue, margins and what each company keeps, and the suppliers and customers both name

RCKTRocket Pharmaceuticals, Inc.

Mkt capRevenueRevenue

MISTMilestone Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

RCKTRocket Pharmaceuticals, Inc.

MISTMilestone Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RCKT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.1%▼−3.85%×0.13

May 8 '26±25.4%▼−1.09%×0.04

Q1 FY26±17.9%▲+10.60%×0.59

Q3 FY25±24.5%▼−1.86%×0.08

MIST1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±57.2%▼−11.42%×0.20

= impliedRCKT realized, solidMIST realized, hatchedOne scale, both sides: full bar = 58%× = |realized| ÷ impliedSource: market data

RCKTRocket Pharmaceuticals, Inc.

2.44▼−3.78%· post 2.44

Mkt cap$267.9MRevenue—

MISTMilestone Pharmaceuticals Inc.

0.73▼−7.26%· post 0.73

ClosedOct 30 '26

Mkt cap$90.9MRevenue$559,000Q2 FY26

Compare

ClosedOct 30 '26

RCKTRocket Pharmaceuticals, Inc.

MISTMilestone Pharmaceuticals Inc.

2.44▼−3.78%post 2.44

Price

0.73▼−7.26%post 0.73

$267.9M

Mkt cap

$90.9M

—

Revenue

$559,000Q2 FY26

RCKT2.44▼−3.78%vsMIST0.73▼−7.26%ClosedOct 30 '26